Middleburg Hts,  OH 
United States
  • Booth: 1929


An FDA Class II medication safety system, Safe Label System reads vial barcodes at the point-of-care. Immediate visual & audible feedback of drug-in-hand reduces errors. On demand, a TJC-compliant syringe label is presented & includes a barcode containing NDC from the vial, scannable at administration to improve documentation. NEW! Pump interoperability in the OR: safer, accurate and automated.

Safe Label System helps increase safety, ensure compliance & improve electronic documentation. Integrates with anesthesia dispensing carts & barcode-enabled EHRs (Epic, Cerner). Visual & audible drug-in-hand confirmation ensures safety. Prints full-color, barcoded syringe label including exact NDC from the vial that can be scanned at administration to increase charge capture & 340B accountability.

 Press Releases

  • BD (Becton, Dickinson and Company), a leading global medical technology company, and Codonics (, a global leader of medication management in the perioperative environment, today announced that the companies have signed an agreement for joint design and development of technology aimed to help improve medication safety in the perioperative area.

    Through this collaboration, BD and Codonics will develop a new solution that aims to intercept medication errors and streamline documentation for IV bolus injections by leveraging BD Intelliport™ technology and Codonics Safe Label System technology.

    • The BD Intelliport™ System: is the first and only solution to provide real-time dose measurement and clinical alerts at the point of injection while wirelessly sending captured information directly into the patient’s electronic medical record (EMR) following medication administration.
    • The Codonics Safe Label System (SLS): is recognized leader in safe medication management installed in more than 7,000 operating rooms worldwide.

    “We’ve found the ideal partner in BD, enabling us to further enhance medication safety in the perioperative environment,” said Peter O. Botten, president and CEO of Codonics. “This partnership enables our existing installed base to easily introduce additional medication safety enhancements by adding BD Intelliport™ technology. It also enables future customers to take advantage of a fully integrated system.”

    By integrating the two technologies, the goal of the joint solution will be to seamlessly identify medication and concentration at the time of administration, helping healthcare workers to intercept medication errors and automate medication administration recordkeeping. Both products have received clearance from the U.S. Food and Drug Administration (FDA) and have been honored with Medical Design Excellence Awards and Best Practice recognitions from Frost & Sullivan.

    “Partnering with Codonics will enable us to better serve healthcare providers who are increasingly focused on delivering safer and more efficient outcomes,” said Lisa Nibauer, vice president and general manager of BD’s Vascular Management Systems. “The combined solution will enable us to leverage the power of technology to improve healthcare delivery by providing our customers with a seamless medication management experience from syringe preparation to delivery.”

    About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit About Codonics Inc. Codonics is a global business, providing healthcare with some of the most advanced patient safety and medical imaging products in the world from its headquarters in Cleveland, Ohio. Since 1982, Codonics has experienced exciting growth and award-winning achievements. Today, the company is represented in 110 countries with more than 50,000 product installations in renowned, cutting-edge medical facilities throughout the world. Codonics commitment to provide innovative products and marketleading solutions is changing the face of healthcare. Driven by a passion to engineer products that improve medication safety so significantly they are recognized as a standard of care throughout the world, Codonics extraordinary team of employees is highly enthusiastic and ultra-focused on improving patient outcomes. To learn more about Codonics, visit